Chinese companies are typically met with a cool reception in the US, except for universities. These institutions engage in contracts worldwide to sell their research and training expertise, with some of the most profitable deals being with Chinese companies. Despite increasing tensions between the US and China, the trade between universities and Chinese businesses continues to flourish.
According to a review by the Wall Street Journal, nearly 200 US colleges and universities had contracts with Chinese companies totaling $2.32 billion between 2012 and 2024. These contracts cover a range of industries, from medicine to agriculture to manufacturing. However, this thriving trade raises concerns about the line between academic research collaboration and empowering a potential US rival, especially in light of growing sensitivity towards Beijing’s influence on American campuses.
Some critics argue that Chinese contracts with US universities give Chinese companies a unique advantage that they cannot obtain elsewhere. The question of which contracts should be legal, discloseable, or illegal is a topic of discussion among policymakers and education department officials. There are concerns that some contracts could pose national security risks, especially if they involve technology transfer or intellectual property theft.
The issue becomes more complex when dealing with companies like WuXi AppTec, known as the “Huawei of pharma”, which has contracts with US universities for research and development activities. Officials in Washington fear that these collaborations could lead to the misuse of technology by Beijing for military purposes. There are calls for stricter oversight and regulations on Chinese contracts with US schools to protect national security interests.
Despite these concerns, there are also many benefits associated with these partnerships